These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26524712)

  • 1. Preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles for anti-Helicobacter pylori therapy.
    Wu Z; Hou J; Wang Y; Chai M; Xiong Y; Lu W; Pan J
    Int J Pharm; 2015 Dec; 496(2):1006-14. PubMed ID: 26524712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary investigations into surface molecularly imprinted nanoparticles for Helicobacter pylori eradication.
    Han J; Sun Y; Hou J; Wang Y; Liu Y; Xie C; Lu W; Pan J
    Acta Pharm Sin B; 2015 Nov; 5(6):577-82. PubMed ID: 26713273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK; Chavda JR
    J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
    Umamaheshwari RB; Ramteke S; Jain NK
    AAPS PharmSciTech; 2004 Apr; 5(2):e32. PubMed ID: 15760090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
    Patel JK; Patel MM
    Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin.
    Moogooee M; Ramezanzadeh H; Jasoori S; Omidi Y; Davaran S
    J Pharm Sci; 2011 Mar; 100(3):1057-66. PubMed ID: 21280053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of nanolipobeads-based dual drug delivery system for H. pylori targeting.
    Jain AK; Jain SK
    J Drug Target; 2013 Jul; 21(6):593-603. PubMed ID: 23597027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
    Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
    Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
    Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
    Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro.
    Cai J; Huang H; Song W; Hu H; Chen J; Zhang L; Li P; Wu R; Wu C
    Int J Pharm; 2015 Nov; 495(2):728-37. PubMed ID: 26417849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori.
    Jing ZW; Jia YY; Wan N; Luo M; Huan ML; Kang TB; Zhou SY; Zhang BL
    Biomaterials; 2016 Apr; 84():276-285. PubMed ID: 26851392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
    Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
    Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
    Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres.
    Harsha S
    Int J Nanomedicine; 2012; 7():4787-96. PubMed ID: 22969298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
    Ramteke S; Ganesh N; Bhattacharya S; Jain NK
    J Drug Target; 2009 Apr; 17(3):225-34. PubMed ID: 19241256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China.
    Ren L; Lu H; Li HY; Zhu LY; Xu XQ; Gu LY; Ge ZZ; Li XB
    J Dig Dis; 2014 Nov; 15(11):622-7. PubMed ID: 25205201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO₂.
    Patel J; Patil P
    J Microencapsul; 2012; 29(4):398-408. PubMed ID: 22292967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.